Medical Marijuana Inc.(OTC:MJNA) has won the 2013 Michigan Medical Marijuana Green Cup and High Times Cannabis Cup award-winner for Highest CBD Concentrate in Seattle and Amsterdam, they also hold a majority stake in Red Dice Holdings that licenses the Dixie Elixirs & Edibles brand that makes the medicated truffle that Sean Azzariti purchased. Visit Medical Marijuana Inc. (OTC:MJNA) website to find out more about why they are a great public cannabis stock to invest in long-term like: US Government Patent #6630507, KannaLife Sciences, CanChew CBD Gum, US Hemp Oil, Cibaderm, Cannabis Beauty DEFINED, Cibdex, Dixie Elixirs, HempMedsPX, HempVAP and more.
Medical Marijuana Inc. (OTC: MJNA) does not own any direct THC bussiness. Red Dice Holdings/Medical Marijuana Inc. is a licensing deal only. A licensing agreement grants a manufacturer the right to develop, market and sell approved products (typically leveraging a company’s brand name, logo(s), mark(s) and/or licensable assets) to approved retailers in return for payment — typically a royalty and guarantee based on wholesale sales as specified in the license agreement.
Typically, Licensing royalties represent 10% of wholesale sales (5% of retail sales) and are paid to licensors on a quarterly basis.
Medical Marijuana Inc. (“MJNA”) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company comprises a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.
These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.
The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid “delivery methods” that are more “socially and medically acceptable” than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.
Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of phyto-cannabinoids. MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies save significantly on resources necessary for production of medical grade cannabis. In addition to providing a medical grade end product, extracts and compounds, PhytoSPHERE Systems also includes pre-and-post production tracking, gemplasm references, packaging and processing to ensure consistency and genetic purity.